Shares of Gerresheimer AG (ETR:GXI – Get Free Report) traded up 1.4% during mid-day trading on Thursday . The stock traded as high as €75.95 ($82.55) and last traded at €75.40 ($81.96). 194,688 shares were traded during trading, an increase of 38% from the average session volume of 140,925 shares. The stock had previously closed at €74.35 ($80.82).
Gerresheimer Price Performance
The stock has a market capitalization of $2.50 billion, a P/E ratio of 21.87, a PEG ratio of 0.82 and a beta of 0.94. The company has a 50 day moving average of €75.46 and a 200-day moving average of €78.80. The company has a quick ratio of 0.40, a current ratio of 0.80 and a debt-to-equity ratio of 87.94.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
See Also
- Five stocks we like better than Gerresheimer
- The Significance of Brokerage Rankings in Stock Selection
- MarketBeat Week in Review – 03/24 – 03/28
- How to Use the MarketBeat Stock Screener
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- 3 Best Fintech Stocks for a Portfolio Boost
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.